Pfizer Faces Stock Slump Amidst Regulatory Challenges
Daily short sale tracking: NVIDIA's short volume increased by 20 million, with a short sale ratio of 11%
Pfizer (NYSE:PFE) Sheds US$13b, Company Earnings and Investor Returns Have Been Trending Downwards for Past Three Years
J.P. Morgan Maintains Pfizer(PFE.US) With Hold Rating, Announces Target Price $30
Pfizer Options Spot-On: On April 4th, 323.29K Contracts Were Traded, With 3.22 Million Open Interest
RFK Jr. to Reinstate 20% of HHS Staff Laid off After DOGE Errors
J.P. Morgan Remains a Hold on Pfizer (PFE)
Express News | Shares of Merck Down 1%, Biogen Down 2.1%, Pfizer Down 1.7%, Eli Lilly Down 3.6% and Abbvie Down 1.3%
Express News | Shares of Some U.S. Drugmakers Down After Trump Says Pharmaceutical Sector Is 'under Review' for Tariffs
Potatoes, Discount Chains and Drugmakers Offer Havens in Stock-market Bloodbath
Pfizer Options Spot-On: On April 3rd, 182.33K Contracts Were Traded, With 3.19 Million Open Interest
FDA Inspections Office Facing Layoffs as Part of HHS Cuts
Better Beaten-Down Stock to Buy: Pfizer Vs. Moderna
Pharma Stocks up on US Tariff Exemptions but Analyst Flags a $46B Import Cost Risk
Is Pfizer Stock a Buy?
Bernstein Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $30
Bernstein Sticks to Its Hold Rating for Pfizer (PFE)
Pfizer (PFE) Increases Yet Falls Behind Market: What Investors Need to Know
Pfizer Options Spot-On: On April 2nd, 143.19K Contracts Were Traded, With 3.14 Million Open Interest
Express News | FDA Says Ketamine Hydrochloride Injection Shortage Resolved as of April 2 - Website